Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL phase II study of metformin to prevent dexamethasone-induced diabetes
2019-000105-73Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in steroid-induced diabetes (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Dec 2020; status: completed.
02
Drugs
metformin
03
Conditions
steroid-induced diabetes
Beyond the preview
Go deeper on 2019-000105-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000105-73.